We also probed for RXRA expression across CML chronic phase (CP), accelerated phase (AP), and blast crisis (BC) patient samples from the GSE4170 dataset and found significantly reduced expression of RXRA in BC-CML samples compared to CP and AP (Figure 3E). This evidence concerns the gene RXRA and chronic myelogenous leukemia, BCR-ABL1 positive.